Brazilian Rare Earths (ASX:BRE) Digs Into Value, Amargosa Study Puts Brazil on the Bauxite Map
Brazilian Rare Earths Red-Hot Run Brazilian Rare Earths (ASX: BRE) surged 8% this morning after releasing a positive scoping study…
What does the Fed rate cut mean for Australia? Will it make a difference whether or not the RBA follows suit in 2026?
Many investors will be asking themselves this question: ‘What does the Fed rate cut mean for Australia?’ This question is…
Droneshield’s Back on Investors Radar, But Who’s Really Flying It?
Droneshield Takes Off Again Droneshield (ASX: DRO) shares jumped 16.2% to close at A$2.26, marking a strong rebound after a…
Medibank Private shares have recovered the losses after the cyber breach 2 years ago, but what’s next?
Medibank Private shares took a big hit nearly 3 years ago due to the infamous cyber breach. Investors who chose…
What is a dead cat bounce, how can you identify one and which 5 stocks are in the midst of them?
The term dead cat bounce has gained popularity in recent years. And there have been plenty of examples of this…
Is Rhythm Biosciences (ASX:RHY) a Buy After Securing NHS Expertise and US Distribution Deal?
Rhythm Biosciences (ASX: RHY) may finally be turning the corner. The company has secured NHS expertise to support its ColoSTAT…
Ramelius Resources (ASX:RMS) Rallies After A$250m Capital Return Program: Should You Buy the Gold Miner?
Ramelius Resources (ASX: RMS) jumped to an intraday high of A$3.71 this week before closing at A$3.57, up 5.6%, after…
Orthocell (ASX:OCC) Surges 7% on First Hong Kong Sales: Is This Healthcare Stock a Buy as Asian Expansion Accelerates?
Orthocell (ASX: OCC) jumped 7% to A$1.09 on Wednesday after announcing its first commercial sales of Remplir in Hong Kong.…
Dateline Resources (ASX:DTR) Drops 20% on Legal Dispute: Is This a Buying Opportunity or Time to Sell?
Dateline Resources (ASX: DTR) dropped 20% to A$0.195 this week, and investors are asking a simple question: is this a…
Moonlight Resources (ASX:ML8) Lists Tomorrow After A$10m IPO: Should You Buy This Gold and Critical Minerals Explorer?
Moonlight Resources (ASX: ML8) will make its ASX debut on 11 December 2025 after completing a A$10 million IPO at…
4DMedical’s Growth Story Gains Airflow in the US Market
4DMedical Finds Its Rhythm 4DMedical (ASX:4DX) climbed 9% today as the company continues to build strong commercial momentum with its…
OpenAI AI Crown Is No Longer Untouchable
OpenAI’s Reign Faces Its First Real Test Many people have heard the headlines claiming that OpenAI is calling a code…
Cogstate (ASX:CGS) Sells Off 22% on Timing Delay, But the Fundamentals Stay Intact
Cogstate’s H1 Hit Is a Timing Story, Not a Demand Story Cogstate Ltd (ASX:CGS) delivered a business update this morning…
Phosco (ASX:PHO): Potential to deliver 67.6Mt of phosphate over nearly 5 decades!
Phosco (ASX:PHO) is bringing its Gasaat phosphate project in Tunisia online. The need for sources of fertilisers like phosphate are…
IGO shares shed 78% in less than 2 years, but are up 40% in 2025! Dead cat bounce or legitimate rebound?
For several years IGO shares reaped the benefits of growing demand for battery metals and the fact it was well…